Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.74
Bid: 5.22
Ask: 6.30
Change: 0.08 (1.41%)
Spread: 1.08 (20.69%)
Open: 5.64
High: 5.74
Low: 5.64
Prev. Close: 5.68
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

9M 2019 Financial Results

19 Nov 2019 07:00

RNS Number : 8272T
Nostrum Oil & Gas PLC
19 November 2019
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

 

London, 19 November 2019

 

 

Financial Results for the Nine months ending 30 September 2019

 

 

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum", or "the Company"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, today announces its financial results in respect of the nine-month period ending 30 September 2019.

 

Overview:

 

Financial:

·; Revenue of US$250.3 million (9M 2018: US$311.4 million)

·; Net operating cash flows[1] of US$160.2 million (9M 2018: US$151.3 million)

·; EBITDA[2] of US$158.3 million (9M 2018: US$187.7 million)

·; EBITDA margin of 63.3% (9M 2018: 60.3%)

·; Closing cash[3] for the period of US$91.3 million (H1 2019: US$120.8 million)

·; Total debt of US$1,113 million and net debt of US$1,021.7 as at 30 September 2019

 

Operational

·; GTU3 commissioning complete

·; 44 wells currently producing - 18 oil wells and 26 gas condensate wells

·; Wells 42 & 41 tested without commercial flows of hydrocarbons

·; Well 361 drilling complete, initial test results show no commercial flow of hydrocarbons

·; 9M 2019 average production after treatment of 28,877 boepd

·; 9M 2019 average sales volumes of 27,515 boepd

·; Schlumberger and PM Lucas reports delivered to the Company

·; Extended licences for the Rostoshinskoye and the Chinarevskoye fields

 

 

Kai-Uwe Kessel, Chief Executive Officer of Nostrum Oil & Gas, commented:

The first nine months of 2019 have been very challenging. We have seen quicker than expected decline in our core producing reservoirs resulting in a reduction in our sales guidance for 2019 by 1,000 boepd. We are analysing the reports provided by Schlumberger and PM Lucas. We continue to explore all options to maximise stakeholder value through our strategic review process. We hope to have concluded this process along with the conclusions from the reports on our reservoirs by year end.

 

GTU3 commissioned

GTU3 is now commissioned. The remaining amount due to contractors on the plant that will be paid in Q4 will be approximately US$14 million.

 

Sales volumesThe sales volumes split for 9M 2019 was as follows:

Products

9M 2019 sales volumes

(boepd)

9M 2019 Product Mix (%)

Crude Oil & Stabilised Condensate 

9,580

34.82

LPG (Liquid Petroleum Gas)

3,680

13.37

Dry Gas

14,255

51.81

Total

27,515

100.00

 

The difference between production after treatment and sales volumes is due to part of the dry gas being used for internal consumption (power generation), gas lift and some losses during transportation.

 

9M 2019 Drilling

·; As at 30 September 2019, the Company had 44 wells in production (18 oil wells and 26 gas-condensate wells).

·; Two wells were drilled during Q3. Well 51, a water injector in to the Tournasian oil reservoir, and appraisal well 361 was drilled in to the Vorobyovsky reservoir in the Northern part of the licence. Initial testing of well 361 has not shown any commercial flow of hydrocarbons.

·; Following extensive testing on well 41 in the Frasnian reservoir Nostrum has so far been unable to sustain a commercial flow of hydrocarbons from the well. The Company will now consider whether there are alternative approaches it can take to perforate other reservoirs. The Company does not forecast any production from this well in 2019.

 

2019 sales volume and 2020 guidance

·; 2019 production guidance was revised down on 29 October 2019 with production forecast at 28,000 boepd and corresponding to sales volumes of 27,000 boepd.

 

·; Guidance for 2020 will be provided once we have concluded the internal analysis on the Schlumberger and PM Lucas reports. This work should be concluded before year end.

 

Licence extensions

The Company has obtained an extension of the Rostoshinskoye field subsoil use contract for appraisal activity for a three-year period until 16 August 2022. In addition, the Company has obtained an extension of the mining permit for the Chinarevskoye field to include the Northern area of the field, which permit is valid for the duration of the licence.

 

 

Conference call

Nostrum's management team will present the 9M 2019 Financial Results and will be available for a Q&A session with analysts and investors today at 14.00 pm BST, 19 November 2019. If you would like to participate in this call, please register by clicking on the following link Results Call and following instructions using the conference ID 7637927.

 

9M 2019 Financial Results presentation

9M 2019 Financial Results

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nog.co.uk 

 

Further enquiries

Nostrum Oil & Gas PLC - Investor Relations

Kirsty Hamilton-Smith

Amy Barlow

+44 203 740 7433

ir@nog.co.uk

Instinctif Partners - UK

David Simonson

Dinara Shikhametova

Sarah Hourahane

nostrum@instinctif.com 

+ 44 (0) 207 457 2020

 

Promo Group Communications - Kazakhstan

Asel Karaulova

Irina Noskova

+ 7 (727) 264 67 37

 

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field, in which it holds a 100% interest and is the operator through its wholly-owned subsidiary Zhaikmunai LLP. In addition, Nostrum Oil & Gas holds a 100% interest in and is the operator of the Rostoshinskoye, Darinskoye and Yuzhno-Gremyachenskoye oil and gas fields through the same subsidiary. Located in the pre-Caspian basin to the north-west of Uralsk, these exploration and development fields are situated approximately 60 and 120 kilometres respectively from the Chinarevskoye field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Partnership or its officers with respect to various matters. When used in this document, the words "expects," "believes," "anticipates," "plans," "may," "will," "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises or guarantees, and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the Listing Rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

9M 2019: Nostrum Financial Results

In millions of US$ (unless mentioned otherwise)

9M 2019

9M 2018

Variance

Variance in %

Revenue

250.3

311.4

(61.1)

(19.6)

EBITDA

158.3

187.7

(29.4)

(15.7)

EBITDA margin (%)

63.3

60.3

3.0%

-

 

In millions of US$ (unless mentioned otherwise)

9M 2019

H1 2019

Variance

Variance in %

Cash Position

91.3

120.8

(29.5)

(24.4)

Net Debt

1,021.7

1,012.0

9.7

1.0

 

 

 

Revenue, EBITDA and Profit for the Period

Revenue from sales of crude oil, stabilised condensate, LPG and dry gas over the period amounted to US$250.3 million for the reporting period, a decrease from the 9M 2018 figure of US$311.4 million. This is mainly explained by a 10.9% decrease in the average Brent crude oil price during the period. EBITDA was US$158.3 million with an EBITDA margin of 63.3%. Profit for the period was US$3.5 million.

 

Cost of sales

The cost of sales during the period was US$115.5 million, a decrease of 10.3 million from the 9M 2018 figure of US$125.8 million.

 

Cash resources and net debt

The Group ended the period with US$91.3 million in cash and cash equivalents (H1 2019: US$120.8 million). Net debt at the end of the period was US$1,021.7 million (H1 2019: US$1,012.0 million).

 

 

 

[1] IFRS term based on indirect cash flow method

[2] Profit before tax net of finance costs, foreign exchange loss/gain, ESOP, depreciation, interest income, other income and expenses

[3] Cash and cash equivalents including current and non-current investments and excluding restricted cash

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTCKCDKDBDKPDD
Date   Source Headline
31st Mar 20238:30 amRNSNostrum Oil & Gas - Capital Markets Day
27th Mar 20237:00 amRNSTR-1: form for notification of major holdings
20th Mar 20238:00 amRNS2023 production guidance
17th Mar 202310:52 amRNSHolding(s) in Company
16th Mar 20233:24 pmRNSDelisting of shares from the official list of KASE
10th Mar 202311:21 amRNSProposed acquisition of Oil & Gas assets
6th Mar 20235:57 pmRNSAppointment of auditors
3rd Mar 202311:49 amRNSNotice of Capital Markets Day
27th Feb 20232:53 pmRNSChanges in Board Committee Composition
24th Feb 20238:46 amRNSStandard form for notification of major holdings
23rd Feb 20235:24 pmRNSHolding(s) in Company
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20238:00 amRNSHolding(s) in Company
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202311:27 amRNSStandard form for notification of major holdings
15th Feb 20239:11 amRNSHolding(s) in Company
14th Feb 20234:24 pmRNSBoard changes
13th Feb 20238:47 amRNSHolding(s) in Company
10th Feb 20237:52 amRNSAdmission to trading on LSE & total voting rights
9th Feb 20234:58 pmRNSCompletion of the Restructuring
7th Feb 20233:13 pmRNSPublication of a Second Supplementary Prospectus
6th Feb 20234:48 pmRNSRestructuring, Sub-Division & Consolidation Update
30th Jan 20234:48 pmRNSUpdate on Restructuring – Required Licences
27th Jan 20237:00 amRNSOperating Update for FY 2022
20th Jan 20234:10 pmRNSProposed Extension of Scheme Longstop Date
9th Jan 20231:36 pmRNSUpdate on Restructuring – OFSI Licence Approval
6th Dec 20225:09 pmRNSPublication of a Supplementary Prospectus
28th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20224:36 pmRNSPrice Monitoring Extension
24th Nov 20224:41 pmRNSSecond Price Monitoring Extn
24th Nov 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSFinancial Results for 3Q and 9M ended 30 Sep 2022
21st Nov 202212:06 pmRNSNotice of Extension of Longstop Date
18th Nov 20224:40 pmRNSSecond Price Monitoring Extn
18th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20224:35 pmRNSPrice Monitoring Extension
11th Nov 20224:41 pmRNSSecond Price Monitoring Extn
11th Nov 20224:35 pmRNSPrice Monitoring Extension
7th Nov 20224:41 pmRNSSecond Price Monitoring Extn
7th Nov 20224:36 pmRNSPrice Monitoring Extension
4th Nov 20224:41 pmRNSSecond Price Monitoring Extn
4th Nov 20224:35 pmRNSPrice Monitoring Extension
4th Nov 20224:32 pmRNSNotice of Proposed Extension of Longstop Date
28th Oct 20227:00 amRNSOperational Update for Q3 and 9M ended 30 Sep 2022
27th Oct 20224:41 pmRNSSecond Price Monitoring Extn
27th Oct 20224:35 pmRNSPrice Monitoring Extension
17th Oct 20224:41 pmRNSSecond Price Monitoring Extn
17th Oct 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.